Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)

被引：4
|
作者：
Trigo, J. [1 ]
Cho, B. C. [2 ]
Park, K. [3 ]
Girard, N. [4 ]
Viteri, S. [5 ]
Garrido, P. [6 ]
Krebs, M. G. [7 ,8 ]
Thayu, M. [9 ]
Knoblauch, R. E. [9 ]
Xie, J. [9 ]
Bauml, J. M. [9 ]
Schnepp, R. W. [9 ]
Londhe, A. [9 ]
Mahadevia, P. [9 ]
Leighl, N. [10 ]
机构：
[1] Hosp Univ Virgen Victoria & Reg, IBIMA, Malaga, Spain
[2] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Inst Curie, Thorax Inst, Paris, France
[5] UOMI Canc Ctr, Clin Mi Tres Torres, Barcelona, Spain
[6] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain
[7] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
[8] Christie NHS Fdn Trust, Manchester Acad, Hlth Sci Ctr, Manchester, Lancs, England
[9] Janssen R&D, Spring House, PA USA
[10] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.02.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20P
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [41] Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)
    Park, S.
    Kim, T. M.
    Kim, S.
    Kim, M.
    Keam, B.
    Kim, D. W.
    Heo, D. S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S110 - S111
  • [42] Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations
    Wang, Yue
    Li, Jingwen
    Zhou, Yan
    Cao, Shuhui
    Ling, Xuxinyi
    Zhang, Yao
    Nie, Wei
    Zhong, Hua
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (20)
  • [43] Amivantamab vs real-world (RW) therapy in Japanese patients with advanced non-small cell lung cancer (aNSCLC) epidermal growth factor receptor (EGFR) exon-20 insertion mutation (E20i)
    Kim, T. M.
    Girard, N.
    Low, G. K. M.
    Zhuo, J.
    Yu, D. Y.
    Yang, Y.
    Murota, M.
    Lim, C.
    Kleinman, N. J.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1058 - S1058
  • [44] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [45] New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations
    David, Gil-Sierra Manuel
    del Pilar, Briceno-Casado Maria
    Cristina, Moreno-Ramos
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 934 - 943
  • [46] A case of non-small cell lung cancer with EGFR exon 20 insertion treated with osimertinib
    Morton-Gittens, Jamie
    Pipalia, Nisarg
    Liu, Hongxiang
    Thippu Jayaprakash, Kamalram
    LUNG CANCER, 2021, 156 : S73 - S74
  • [47] Effect of Local Therapy on Survival in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC)
    Soon, Y. Y.
    Lee, C. C.
    Koh, W. Y.
    Leong, C. N.
    Tey, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S356 - S356
  • [48] Positive progress for non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: A novel targeted therapy option
    Zhang, Weisan
    Dong, Xifeng
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 2007 - 2009
  • [49] Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088
    Loong, H. H. F.
    Daniele, G.
    Yang, T-Y.
    Leal, T. A.
    Goto, K.
    Shinno, Y.
    Nishino, K.
    Sakamoto, T.
    Felip, E.
    Ruffinelli, J. C.
    Gallot, N.
    Wang, Z.
    Chen, C.
    Brennan, B.
    Pu, S-F.
    Kornacker, M.
    Grassi, P.
    Le, X.
    Tan, D. S. W.
    Goh, B-C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [50] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
12345